Bayer, Bausch Health & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Bausch Health and Salix Pharmaceuticals settled outstanding intellectual property claims against their drug Xifaxan from generic drugmaker Actavis Laboratories.

Bayer added a warning to its prescription-free stomach relief Iberogast drops after a patient died from the product.

The FDA awarded Motus GI's Pure-Vu Slim Sleeve 510(k) clearance, expanding Motus' reach to encompass the full range of gastrointestinal procedures.

Prescient Medicine Holdings and Metabiomics partnered to develop a microbiome diagnostic platform to diagnose gastrointestinal diseases including Crohn's disease, ulcerative colitis and irritable bowel syndrome.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast